Sebastian Wehle
Director/Board Member at TIGENIX NV
Profile
Sebastian Wehle is currently working as an Executive Director at TiGenix NV since 2018.
Prior to this, he worked as the Head-Alofisel Manufacturing & Supply at Takeda Pharmaceutical Co., Ltd.
Dr. Wehle holds a doctorate degree from the University of Kiel.
Sebastian Wehle active positions
| Companies | Position | Start |
|---|---|---|
| TIGENIX NV | Director/Board Member | 2018-06-14 |
Former positions of Sebastian Wehle
| Companies | Position | End |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Training of Sebastian Wehle
| University of Kiel | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
TiGenix NV
 TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
- Stock Market
- Insiders
- Sebastian Wehle
